Replies to post #214412 on Biotech Values

[ghmm]

QURE:

Speaking of which... This is an interesting development

uniQure Announces Hemophilia B Gene Therapy Program To Enter Pivotal Study With FIX-Padua Variant in 2018

https://tools.eurolandir.com/tools/Pressreleases/GetPressRelease/?ID=3388861&lang=en-GB&companycode=nl-qure&v=

CC at 8:30am ET:
https://edge.media-server.com/m6/p/xoa7ar3j